ETFChannel.com
MRNA Description — Moderna Inc

Moderna is a clinical stage biotechnology company creating medicines based on messenger RNA (mRNA) to improve the lives of patients. mRNA medicines are designed to direct the body's cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a broad spectrum of diseases. Co.'s platform builds on basic and applied mRNA science, delivery technology, and manufacturing, providing it the capability to pursue in parallel a robust pipeline of new development candidates. Co. is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases.

Company Name: 
Moderna Inc
Website: 
www.modernatx.com
Sector: 
Biotechnology
Number of ETFs Holding MRNA: 
95
Total Market Value Held by ETFs: 
$14,151,744,510
Total Market Capitalization: 
$140,262,000,000
% of Market Cap. Held by ETFs: 
10.09%
 ETF   MRNA Weight   MRNA Amount 
 VTI   0.26%   $3,307,029,833         
 QQQ   0.97%   $1,775,189,793         
 VXF   1.27%   $1,490,771,964         
 SPY   0.28%   $1,074,167,295         
 IBB   8.97%   $972,299,861         
 VUG   0.53%   $904,034,203         
 IVV   0.28%   $829,049,081         
 XLV   2.11%   $673,983,065         
 MTUM   2.77%   $408,143,160         
 IWF   0.53%   $384,686,617         
List of all 95 ETFs holding MRNA »
Quotes delayed 20 minutes

Buy (2.54 out of 4)
3rd percentile
(ranked lower than approx. 97% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com

ETFs Holding MRNA | Moderna Inc | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2021, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.